From India Rating & Research
Claris Lifesciences announced that the 'India Rating & Research (Ind-Ra)' has affirmed Claris Lifesciences ("CLL") Long Term Rating at 'IND A' with a "Stable" outlook.Powered by Capital Market - Live News
Claris Lifesciences gets reaffirmation of credit ratings
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 16 2016 | 6:10 PM IST
